Indoleamine 2,3 dioxygenase and metabolic control of immune responses

Munn, David H., Mellor, Andrew L.·2013·Trends in Immunology

Cited by (1,000)

Items 501–600 of 1,000

  1. Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics
    Ginevra Urbani, Elena Rondini, Eleonora Distrutti, Silvia Marchianò, Michele Biagioli, Stefano Fiorucci · 2025 · Cells
  2. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
    Rebeca Vidal, Nuria García‐Marchena, Esther O’Shea, Nerea Requena-Ocaña, María Flores-López, Pedro Fernando Araos, Antonia Serrano, Juan Suárez, Gabriel Rubio, Fernando Rodrı́guez de Fonseca et al. · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  3. Self‐Delivering Nanodrugs Developed via Small‐Molecule‐Directed Assembly and Macrophage Cloaking for Sonodynamic‐Augmented Immunotherapy
    Fang Xie, Zongjunlin Liu, Peiyuan Wang, Meimei Cai, Yang Li, Jianghua Yan, Qin Lin, Fanghong Luo · 2022 · Advanced Healthcare Materials
  4. Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment
    Cristina Viúdez-Pareja, Ewa A. Kreft, Melissa García‐Caballero · 2023 · Frontiers in Immunology
  5. Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders
    Takeshi Kondo, Yuka Okada, Shizuya Saika, Naoko Yamaguchi, Shigetsugu Hatakeyama, Kenta Maruyama · 2024 · European Journal of Cell Biology
  6. Indoleamine 2,3-dioxygenase: First evidence of expression in rainbow trout (Oncorhynchus mykiss)
    Jimena Cortés, Claudio Álvarez, Paula Santana, Elisa Torres, Luis A. Mercado · 2016 · Developmental & Comparative Immunology
  7. Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
    Ornella Franzese, Francesco Torino, Maria Pia Fuggetta, Angelo Aquino, Mario Roselli, Enzo Bonmassar, Anna Giuliani, Stefania D’Atri · 2017 · Oncotarget
  8. Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1
    Mateusz Tomczyk, Izabela Kraszewska, Józef Dulak, Agnieszka Jaźwa · 2018 · Vascular Pharmacology
  9. PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I
    Shin Ishihara, Yuichi Yamada, Takeshi Iwasaki, Masato Yoshimoto, Yu Toda, Kenichi Kohashi, Hidetaka Yamamoto, Yoshihiro Matsumoto, Yasuharu Nakashima, Yoshinao Oda · 2020 · Oncology Reports
  10. IDO and CD40 May Be Key Molecules for Immunomodulatory Capacity of the Primed Tonsil-Derived Mesenchymal Stem Cells
    Hyun-Joo Lee, Harry Jung, Dong‐Kyu Kim · 2021 · International Journal of Molecular Sciences
  11. Dietary therapies for adult and pediatric inflammatory bowel disease
    Jessica Deas, Neha D. Shah, Gauree Gupta Konijeti, Abigail Lundin, Olivia Lanser, Pooja R. Magavi, Sabina A. Ali · 2024 · Nutrition in Clinical Practice
  12. Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting
    Can Chen, Yaping Xie, Shenxian Qian · 2024 · Translational Oncology
  13. Human Wharton’s Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients
    Mairvat Al-Mrahleh, Suzan A. Matar, Hanan D. Jafar, Suha Wehaibi, Nazneen Aslam, Abdalla Awidi · 2021 · Frontiers in Immunology
  14. Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer
    Beatrice Aramini, Valentina Masciale, Anna Valeria Samarelli, Alessandra Dubini, Michele Gaudio, Franco Stella, Uliano Morandi, Massimo Dominici, Sara De Biasi, Lara Gibellini et al. · 2022 · Frontiers in Immunology
  15. The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus
    Débora Moitinho Abram, Luís Gustavo Romani Fernandes, Antonio Ramos Filho, Patrícia Ucelli Simioni · 2017 · Drug Design Development and Therapy
  16. Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface
    Costa, Maria Laura, Robinette, Michelle L., Bugatti, Mattia, Longtine, Mark S., Colvin, Bryanne N., Lantelme, Erica, Vermi, William, Colonna, Marco, Nelson, D. Michael, Cella, Marina · 2017 · Frontiers in Immunology
  17. Targeting Type 1 Diabetes: Selective Approaches for New Therapies
    Daniel F. Sheehy, Sean P. Quinnell, Arturo J. Vegas · 2019 · Biochemistry
  18. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
    Henrique de Paula Lemos, Eslam T. Mohamed, Rong Ou, Caroline McCardle, Xiaozhong Zheng, Kris McGuire, Natalie Z M Homer, Damian J. Mole, Lei Huang, Andrew L. Mellor · 2020 · Frontiers in Immunology
  19. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity
    Noëlla Lopes, Bruno Silva‐Santos · 2020 · European Journal of Immunology
  20. Role of Kynurenine and Its Derivatives in the Neuroimmune System
    Makoto Fujikawa, Masashi Ueda, Kenta Maruyama · 2024 · International Journal of Molecular Sciences
  21. Exercise-induced adaptations in the kynurenine pathway: implications for health and disease management
    Marcus Vinícius dos Santos Rangel, Karynne Grutter Lopes, Xuebin Qin, Juliana Pereira Borges · 2025 · Frontiers in Sports and Active Living
  22. Radiotherapy in the age of cancer immunology: Current concepts and future developments
    Mauro Loi, Isacco Desideri, Daniela Greto, Monica Mangoni, Mariangela Sottili, Icro Meattini, Carlotta Becherini, Francesca Terziani, Camilla Delli Paoli, Emanuela Olmetto et al. · 2017 · Critical Reviews in Oncology/Hematology
  23. Human Indoleamine 2,3-Dioxygenase 1 Is an Efficient Mammalian Nitrite Reductase
    Yean Jin Lim, Timothy C. Foo, Amanda W. S. Yeung, Xiaofan Tu, Yuanqing Ma, Clare Louise Hawkins, Paul Kenneth Witting, Guy N. L. Jameson, Andrew C. Terentis, Shane Ross Thomas · 2018 · Biochemistry
  24. Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor
    Shuguang Ma, Julia Suchomel, Evelyn Yanez, Edward Yost, Xiaorong Liang, Rui Zhu, Hoa Thi Le, Nicholas Siebers, Lori Joas, Roland Morley et al. · 2019 · British Journal of Clinical Pharmacology
  25. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas
    Madhumeeta Chadha, Paul H. Huang · 2022 · Current Treatment Options in Oncology
  26. The Kynurenine Pathway and Mediating Role of Stress in Addictive Disorders: A Focus on Alcohol Use Disorder and Internet Gaming Disorder
    Joon Hwan Jang, So Young Yoo, Yae Eun Park, Mi-Jung Ji, Hyun‐Mee Park, Ji Hyun Back, Ji Yoon Lee, Dai‐Jin Kim, Ji Eun Lee, Jung‐Seok Choi · 2022 · Frontiers in Pharmacology
  27. Innate immunity champions: The diverse functions of macrophages
    Francesca Biscu, Anissa Zouzaf, Donatella Cicia, Clare Pridans, Gianluca Matteoli · 2024 · European Journal of Immunology
  28. STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?
    Henrique de Paula Lemos, Lei Huang, Tracy L. McGaha, Andrew L. Mellor · 2014 · Expert Review of Clinical Immunology
  29. Hyperoxygenation Attenuated a Murine Model of Atopic Dermatitis through Raising Skin Level of ROS
    Hyung‐Ran Kim, Junghwan Kim, Eun-Jeong Choi, Jeong-Hae Kie, Myoung Ho Jang, Ju-Young Seoh · 2014 · PLoS ONE
  30. Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma
    Qiyi Zhao, Peipei Wang, Zhanlian Huang, Liang Peng, Chaoshuang Lin, Zhiliang Gao, Shicheng Su · 2016 · Oncotarget
  31. Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools
    Jaris Valencia, Eva Jiménez, Víctor G. Martínez, Beatriz G. del Amo, Laura Hidalgo, Ana Entrena, Lidia M. Fernández-Sevilla, Francisco del Rio, Alberto Varas, Ángeles Vicente et al. · 2017 · Cytotherapy
  32. RNA-Seq based transcriptome of whole blood from immunocompetent pigs (Sus scrofa) experimentally infected with Mycoplasma suis strain Illinois
    Naíla Cannes do Nascimento, Ana M. S. Guimarães, Andrea Pires dos Santos, Yuefeng Chu, Lucas Miranda Marques, Joanne B. Messick · 2018 · Veterinary Research
  33. Targeting the kynurenine pathway in gliomas: Insights into pathogenesis, therapeutic targets, and clinical advances
    Mikolaj M. Krupa, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, Tomasz Łysoń · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  34. Metabolomics analysis of gut barrier dysfunction in a trauma-hemorrhagic shock rat model
    Zhongqi Li, Jian Li, Shouwei Zhang, Gang Chen, Shaohua Chi, Xugang Li, Fei Guo, Jianbo Zhu, Baoxi Sun · 2018 · Bioscience Reports
  35. Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone
    Yang I Lin, Heyanhao Zhang, Tong Niu, Mei‐Lin Tang, Jun Chang · 2020 · Molecules
  36. Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
    Antero Salminen · 2020 · Neurochemistry International
  37. Aryl hydrocarbon receptor–targeted therapy for CD4+ T cell–mediated idiopathic pneumonia syndrome in mice
    Soung-Min Lee, Chae Eun Kim, Ha Young Park, Eun Hye Yoon, Hae Jeong Won, Joo Mi Ahn, Nu Z. N. Nguyen, Minji Kim, Won Hee Jang, Won Sik Lee et al. · 2022 · Blood
  38. A matter of time: temporal structure and functional relevance of macrophage metabolic rewiring
    Gretchen L. Seim, Jing Fan · 2022 · Trends in Endocrinology and Metabolism
  39. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis
    Albert J. Czaja · 2021 · Digestive Diseases and Sciences
  40. The Kynurenine Pathway in Obese Middle-Aged Women with Normoglycemia and Type 2 Diabetes
    Justyna Kubacka, Magdalena Maria Staniszewska, Ilona Sadok, Grażyna Sypniewska, Anna Stefańska · 2022 · Metabolites
  41. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms
    Mohsen Karami Fath, Kimiya Babakhaniyan, Mehran Anjomrooz, Mohammad-Rasoul Jalalifar, Seyed Danial Alizadeh, Zeinab Pourghasem, Parisa Abbasi Oshagh, Ali Azargoonjahromi, Faezeh Almasi, Hafza Zahira Manzoor et al. · 2022 · Vaccines
  42. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy
    Yinhui Wang, Jia Ge Song, Kun Yu, Daan Nie, Chengcheng Zhao, Liping Jiao, Ziyi Wang, Ling Zhou, Feng Wang, Qilin Yu et al. · 2023 · Hypertension
  43. Variation of genes encoding KAT1, AADAT and IDO1 as a potential risk of depression development
    Paulina Wigner, Piotr Lech Czarny, Ewelina Synowiec, Michał Bijak, Monika Ewa Talarowska, Piotr Gałecki, Janusz Szemraj, Tomasz Śliwiński · 2018 · European Psychiatry
  44. Cell based functional assays for IDO1 inhibitor screening and characterization
    Thomas Richards, Elena Brin · 2018 · Oncotarget
  45. Bystander inhibition of humoral immune responses by Epstein–Barr virus LMP1
    Chao‐Yuan Tsai, Shuhei Sakakibara, Teruhito Yasui, Takeharu Minamitani, Daisuke Okuzaki, Hitoshi Kikutani · 2018 · International Immunology
  46. Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase
    Shixian Hua, Feihong Chen, Xinyi Wang, Shaohua Gou · 2020 · European Journal of Medicinal Chemistry
  47. Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
    Ce Chen, Jialin Wang, Mengqin Cheng, Haifeng Xie, Wei Li, Chaofeng Zhang · 2025 · Pharmacological Research
  48. Induction of Immune Tolerance to Dietary Antigens
    Kwang Soon Kim, Charles D. Surh · 2015 · Advances in experimental medicine and biology
  49. Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases
    Fabiany da Costa Gonçalves, Ana Helena da Rosa Paz · 2019 · World Journal of Stem Cells
  50. A First Plasmodium vivax Natural Infection Induces Increased Activity of the Interferon Gamma-Driven Tryptophan Catabolism Pathway
    Rafaella Oliveira dos Santos, Maria Geuziane Soares da Cruz, Stefanie Costa Pinto Lopes, Lucas Barbosa Oliveira, Paulo Afonso Nogueira, Émerson Silva Lima, Irene S. Soares, Flora Satiko Kano, Andréa Teixeira‐Carvalho, Fábio Trindade Maranhão Costa et al. · 2020 · Frontiers in Microbiology
  51. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
    Lisa Wetzel, Myrna Hurtado, Zoë A. MacDowell Kaswan, Robert H. McCusker, Andrew J. Steelman · 2020 · Brain Behavior & Immunity - Health
  52. Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications
    Alice Indini, Francesco Grossi, Mario Mandalà, Daniela Taverna, Valentina Audrito · 2021 · Biomedicines
  53. Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome
    Chang Liu, Kun Xiao, Lixin Xie · 2022 · Frontiers in Cell and Developmental Biology
  54. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells
    Jennifer R. Richardson, Nicole S. Armbruster, Manina Günter, Jörg C. Henes, Stella E. Autenrieth · 2018 · Frontiers in Immunology
  55. Mechanism of indoleamine 2, 3‐dioxygenase inhibiting cardiac allograft rejection in mice
    Chuan Li, Zhaonan Sun, Fang Yuan, Zhicheng Zhao, Jiehong Zhang, Baotong Zhang, Hongyue Li, Tong Liu, Xiangchen Dai · 2020 · Journal of Cellular and Molecular Medicine
  56. Continuing Effect of Cytokines and Toll-Like Receptor Agonists on Indoleamine-2,3-Dioxygenase-1 in Human Periodontal Ligament Stem/Stromal Cells
    Christian Behm, Alice Blufstein, Johannes Gahn, Barbara Kubin, Andreas Moritz, Xiaohui Rausch‐Fan, Oleh Andrukhov · 2020 · Cells
  57. Cell‐Based Identification of New IDO1 Modulator Chemotypes
    Elisabeth Hennes, Philipp Lampe, Lara Dötsch, Nora Bruning, Lisa‐Marie Pulvermacher, Sonja Sievers, Slava Ziegler, Herbert Waldmann · 2021 · Angewandte Chemie International Edition
  58. Methionine and Tryptophan Play Different Modulatory Roles in the European Seabass (Dicentrarchus labrax) Innate Immune Response and Apoptosis Signaling—An In Vitro Study
    Marina Machado, Cláudia R. Serra, Aires Oliva‐Teles, Benjamín Costas · 2021 · Frontiers in Immunology
  59. Indoleamine 2, 3-dioxygenase 1 inhibition mediates the therapeutic effects in Parkinson's disease mice by modulating inflammation and neurogenesis in a gut microbiota dependent manner
    Chen-Meng Qiao, Xiaoyu Ma, Lulu Tan, Yi-Meng Xia, Ting Li, Jian Wu, Chun Cui, Wei-Jiang Zhao, Yan‐Qin Shen · 2025 · Experimental Neurology
  60. Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitis
    Alexander Lercher, Alexandra Popa, Csilla Viczenczová, Lindsay Kosack, Kristaps Klavins, Benedikt Agerer, Christiane A. Opitz, Tobias Volker Lanz, Michael Platten, Andreas Bergthaler · 2020 · PLoS Pathogens
  61. Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
    Natalia García‐Sancha, Roberto Corchado‐Cobos, Lorena Bellido-Hernández, Concepción Román‐Curto, Esther Cardeñoso Álvarez, Jesús Pérez‐Losada, Alberto Órfão, Javier Cañueto · 2021 · Cancers
  62. Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
    Tiantian Qiu, Donghua Li, Yu Liu, Hui Ren, Xuan Yang, Wenting Luo · 2022 · Cancers
  63. Tryptophan Modulatory Role in European Seabass (Dicentrarchus labrax) Immune Response to Acute Inflammation under Stressful Conditions
    Marina Machado, Diogo Peixoto, Paulo Santos, Ana Ricardo, Inês Duarte, Inês Carvalho, Cláudia Aragão, Rita Azeredo, Benjamín Costas · 2022 · International Journal of Molecular Sciences
  64. Construction of CAR-T cells targeting TM4SF1 and its anti-tumor capacity in ovarian cancer
    Yijie Shen, Guodi Liu, Qian Zhang, Xiaoli Tian, Liming Ouyang, Lixin Zhang · 2023 · Immunology Letters
  65. Microbial Components and Effector Molecules in T Helper Cell Differentiation and Function
    Changhon Lee, Haena Lee, John Chulhoon Park, Sin‐Hyeog Im · 2023 · Immune Network
  66. Tryptophan, an important link in regulating the complex network of skin immunology response in atopic dermatitis
    Yaxin Huang, Lingna Chen, Fuming Liu, Xia Xiong, Yongliang Ouyang, Yongqiong Deng · 2024 · Frontiers in Immunology
  67. Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model
    Reza B. Jalili, Ruhangiz Taghi Kilani, Yunyuan Li, Mohsen Khosravi-maharlooie, Layla Nabai, Eddy Hsi Chun Wang, Kevin John McElwee, Aziz Ghahary · 2018 · Cell Transplantation
  68. TLR3 activation modulates immunomodulatory properties of human periodontal ligament cells
    Daneeya Chaikeawkaew, Vincent E. Everts, Prasit Pavasant · 2020 · Journal of Periodontology
  69. Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
    Shushan Ge, Haiqing Zhong, Xuewei Ma, Yingbo Zheng, Yi Zou, Fang Wang, Yan Wang, Yue Hu, Yuezhen Li, Wen Liu et al. · 2020 · Journal of Enzyme Inhibition and Medicinal Chemistry
  70. Participation of mesenchymal stem cells in the regulation of immune response and cancer development
    Marta Elena Castro-Manrreza · 2016 · Boletín Médico del Hospital Infantil de México
  71. Foreskin as a Source of Immunotherapeutic Mesenchymal Stromal Cells
    Mehdi Najar, Laurence Lagneaux · 2017 · Immunotherapy
  72. Spatial heterogeneity in glioblastoma: Decoding the role of perfusion
    Shubhraneel Saha, Anjali Bhat, Samiksha Kukal, Manoj Phalak, Saran Kumar · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  73. Tim-3 downregulation by Toxoplasma gondii infection contributes to decidual dendritic cell dysfunction
    Hongbing Xie, Zhidan Li, Guangmei Zheng, Chunyan Yang, Xianbing Liu, Xiaoyan Xu, Yushan Ren, Chao Wang, Xuemei Hu · 2022 · Parasites & Vectors
  74. Immunometabolism: a new dimension in immunotherapy resistance
    Chaoyue Xiao, Wei Xiong, Yiting Xu, Jian Peng Zou, Yue Zeng, Junqi Liu, Yurong Peng, Chunhong Hu, Fang Wu · 2023 · Frontiers of Medicine
  75. Engineering metabolism to modulate immunity
    Senta M. Kapnick, Corinne A. Martin, Christopher M. Jewell · 2023 · Advanced Drug Delivery Reviews
  76. Application of adipose-derived stem cells in ischemic heart disease: theory, potency, and advantage
    Weizhang Xiao, Jia-Hai Shi · 2024 · Frontiers in Cardiovascular Medicine
  77. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis
    Karen Put, Ellen Brisse, Anneleen Avau, Maya Imbrechts, Tania Mitera, Rik Janssens, Paul Proost, Francesca Fallarino, Carine Helena Wouters, Patrick Matthys · 2016 · PLoS ONE
  78. Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away
    Alexander T.J. Lee, Paul H. Huang, Ronald P. DeMatteo, Seth M. Pollack · 2016 · American Society of Clinical Oncology Educational Book
  79. Tyrosine kinase inhibitors modulate dendritic cell activity via confining c-Kit signaling and tryptophan metabolism
    Ching‐Liang Chu, Yi‐Pang Lee, Cheng‐Yoong Pang, Huei‐Ru Lin, Chang-Shan Chen, Ren-In You · 2020 · International Immunopharmacology
  80. The role of indoleamine 2,3‐dioxygenase in allergic disorders
    Seyed‐Alireza Esmaeili, Jafar Hajavi · 2022 · Molecular Biology Reports
  81. Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
    Gang Meng, Ziwei Fei, Mingyue Fang, Binghua Li, Anxian Chen, Chun Xu, Xia Mao, Decai Yu, Jiwu Wei · 2019 · Molecular Therapy — Oncolytics
  82. The Metabolic Cytokine Adiponectin Inhibits Inflammatory Lung Pathology in Invasive Aspergillosis
    Nansalmaa Amarsaikhan, Angar Tsoggerel, Christopher Hug, Steven P. Templeton · 2019 · The Journal of Immunology
  83. From multi-omics to predictive biomarker: AI in tumor microenvironment
    Luo Hai, Ziming Jiang, Haoxuan Zhang, Yingli Sun · 2024 · Frontiers in Immunology
  84. Indoleamine-2,3-dioxygenase: An important controller in maintaining mesenchymal stem cell-mediated immunomodulatory homeostasis
    Yufei Hui, Xue Jiao, Li Yang, Dejin Lu, Yanbo Han, Wen Yang, Yanli Cao, Yuxi Miao, Shiqiang Gong, Minjie Wei · 2025 · Acta Pharmaceutica Sinica B
  85. Metabolism of Immune Cells in the Tumor Microenvironment
    Jin Gyoung Jung, Anne Le · 2021 · Advances in experimental medicine and biology
  86. Kynurenines in polycystic kidney disease
    Jost Klawitter, Matthew J. Jackson, Peter H. Smith, Katharina Hopp, Michel Chonchol, Berenice Y. Gitomer, Melissa A. Cadnapaphornchai, Uwe Christians, Jelena Klawitter · 2022 · Journal of Nephrology
  87. Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
    Sarah Y. Kado, Keith J. Bein, Alejandro R. Castañeda, Arshia A. Pouraryan, Nicole Garrity, Yasuhiro Ishihara, Andrea Rossi, Thomas Haarmann‐Stemmann, Colleen A. Sweeney, Christoph F. A. Vogel · 2023 · Cells
  88. Common alterations in plasma free amino acid profiles and gut microbiota-derived tryptophan metabolites of five types of cancer patients
    Ahad Hussain, Li Xie, Guozhe Deng, Xuejun Kang · 2023 · Amino Acids
  89. The Kynurenine/Tryptophan Ratio as a Promising Metabolomic Biomarker for Diagnosing the Spectrum of Tuberculosis Infection and Disease
    Fitri Fadhilah, Agnes Rengga Indrati, Sumartini Dewi, Prayudi Santoso · 2023 · International Journal of General Medicine
  90. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy
    Xun Wang, Bin Yan, Hugang Li, Jianlan Yuan, Jingyi Guo, Siyao Wang, Penggao Dai, Xiaoli Liu · 2024 · ACS Applied Materials & Interfaces
  91. Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3
    Elisabeth Hennes, Belén Lucas, Natalie S. Scholes, Xiu‐Fen Cheng, Daniel C. Scott, Matthias Bischoff, Katharina Reich, Raphael Gasper, María Lucas, Teng Teng Xu et al. · 2026 · Nature Chemistry
  92. Learning from other diseases: protection and pathology in chronic fungal infections
    Teresa Zelante, Giuseppe Pieraccini, Lucia Scaringi, Franco Aversa, Luigina R. Romani · 2015 · Seminars in Immunopathology
  93. Strategies to Relieve Immunosuppression in Pancreatic Cancer
    Max M. Schnurr, Peter Duewell, Christian Alexander Bauer, Simon Rothenfußer, Kirsten Lauber, Stefan Endres, Sebastian Kobold · 2015 · Immunotherapy
  94. Gastro-intestinal tract: The leading role of mucosal immunity
    Anna Steinert, Katarina Radulovic, Jan Hendrik Niess · 2016 · Swiss Medical Weekly
  95. Identification and preliminary structure–activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors
    Dingding Gao, Yingxia Li · 2017 · Bioorganic & Medicinal Chemistry
  96. Effect of the IDO Gene on Pregnancy in Mice with Recurrent Pregnancy Loss
    Hui Cheng, Yongli Huang, Guanyou Huang, Zhuo Chen, Jia Tang, Lina Pan, Jing Lv, Aizhuan Long, Rui Wang, Zengchunxiao Chen et al. · 2020 · Reproductive Sciences
  97. Untargeted metabolomics analysis reveals Mycobacterium tuberculosis strain H37Rv specifically induces tryptophan metabolism in human macrophages
    Guohui Xiao, Su Zhang, Like Zhang, Shuyan Liu, Guobao Li, Min Ou, Xuan Zeng, Zhaoqin Wang, Guoliang Zhang, Shuihua Lu · 2022 · BMC Microbiology
  98. Cross-sectional examination of metabolites and metabolic phenotypes in uremia
    Sahir Kalim, Clary B. Clish, Joseph J. Deferio, Guillermo A. Ortiz, Alexander S. Moffet, Robert Edgardo Gerszten, Ravi Thadhani, Eugene P. Rhee · 2015 · BMC Nephrology
  99. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial
    Bertrand Lebouché, Mohammad-Ali Jenabian, Joel Singer, Gina M. Graziani, Kim Engler, Benoît Trottier, Réjean Thomas, Marie‐Josée Brouillette, Jean‐Pierre Routy · 2014 · Trials
  100. The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma
    Miia Seppälä, Elina Halme, Lauri Tiilikainen, Annika T. Luukkainen, Jussi E. Laranne, Markus Rautiainen, Heini Huhtala, Timo Paavonen, Sanna Katriina Toppila-Salmi · 2016 · Acta Oto-Laryngologica